Periodontitis promotes tumor growth and immune evasion via PD-1/PD-L1.

IF 4.6 2区 医学 Q2 IMMUNOLOGY Cancer Immunology, Immunotherapy Pub Date : 2024-11-13 DOI:10.1007/s00262-024-03865-5
Suli Wang, Fujiao Nie, Qiuyue Yin, Haoyang Tian, Pizhang Gong, Jinhong Ju, Jiayi Liu, Pishan Yang, Chengzhe Yang
{"title":"Periodontitis promotes tumor growth and immune evasion via PD-1/PD-L1.","authors":"Suli Wang, Fujiao Nie, Qiuyue Yin, Haoyang Tian, Pizhang Gong, Jinhong Ju, Jiayi Liu, Pishan Yang, Chengzhe Yang","doi":"10.1007/s00262-024-03865-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Our study investigated the role of experimental periodontitis on tumor growth, local and systemic immunosuppressive status, and programmed death receptor 1 (PD-1) / programmed death ligand 1 (PD-L1) expression in oral squamous cell carcinoma (OSCC) and prostate cancer.</p><p><strong>Methods: </strong>Mouse oral or prostate cancer xenograft models were divided into control, periodontitis and periodontitis + anti-PD-1 groups. Tumor volume and weight were recorded and the levels of relevant immune-suppressive cells and T cells were detected by flow cytometry or immunofluorescence. THP-1 cells were stimulated using conditioned media of LPS-stimulated Cal-27 cells and PD-L1 expression was measured by quantitative real-time PCR, western blotting and immunofluorescence. Tumor specimens from OSCC patients with or without periodontitis were also collected for immunofluorescence.</p><p><strong>Results: </strong>Periodontitis significantly promoted tumor volume and weight. Compared to the control, the proportions of tumor-associated macrophages (TAMs), regulatory T cells (Tregs), PD-L1<sup>+</sup>TAMs and PD-1<sup>+</sup>CD8<sup>+</sup>T cells increased, while CD8<sup>+</sup>T cells decreased in the periodontitis group. Immunofluorescence demonstrated that there was an increase in PD-L1<sup>+</sup>TAMs and PD-1<sup>+</sup>CD8<sup>+</sup>T cells, but a decrease in IFN-γ<sup>+</sup>CD8<sup>+</sup>T cells in both xenografts and clinical OSCC samples with periodontitis. In vitro, LPS-stimulated Cal-27 cells had a stronger potential to induce PD-L1 expression in macrophages compared with unstimulated Cal-27 cells. And the promoting effect of periodontitis on tumor growth and immune evasion was significantly attenuated after anti-PD-1 therapy.</p><p><strong>Conclusion: </strong>Periodontitis may facilitate tumor growth and immune escape evidenced by the increased immune-suppressive cells and the decreased functional T cells, via enhancing PD-1/PD-L1 expression in the tumor microenvironment.</p>","PeriodicalId":9595,"journal":{"name":"Cancer Immunology, Immunotherapy","volume":"74 1","pages":"22"},"PeriodicalIF":4.6000,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11561227/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Immunology, Immunotherapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00262-024-03865-5","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Our study investigated the role of experimental periodontitis on tumor growth, local and systemic immunosuppressive status, and programmed death receptor 1 (PD-1) / programmed death ligand 1 (PD-L1) expression in oral squamous cell carcinoma (OSCC) and prostate cancer.

Methods: Mouse oral or prostate cancer xenograft models were divided into control, periodontitis and periodontitis + anti-PD-1 groups. Tumor volume and weight were recorded and the levels of relevant immune-suppressive cells and T cells were detected by flow cytometry or immunofluorescence. THP-1 cells were stimulated using conditioned media of LPS-stimulated Cal-27 cells and PD-L1 expression was measured by quantitative real-time PCR, western blotting and immunofluorescence. Tumor specimens from OSCC patients with or without periodontitis were also collected for immunofluorescence.

Results: Periodontitis significantly promoted tumor volume and weight. Compared to the control, the proportions of tumor-associated macrophages (TAMs), regulatory T cells (Tregs), PD-L1+TAMs and PD-1+CD8+T cells increased, while CD8+T cells decreased in the periodontitis group. Immunofluorescence demonstrated that there was an increase in PD-L1+TAMs and PD-1+CD8+T cells, but a decrease in IFN-γ+CD8+T cells in both xenografts and clinical OSCC samples with periodontitis. In vitro, LPS-stimulated Cal-27 cells had a stronger potential to induce PD-L1 expression in macrophages compared with unstimulated Cal-27 cells. And the promoting effect of periodontitis on tumor growth and immune evasion was significantly attenuated after anti-PD-1 therapy.

Conclusion: Periodontitis may facilitate tumor growth and immune escape evidenced by the increased immune-suppressive cells and the decreased functional T cells, via enhancing PD-1/PD-L1 expression in the tumor microenvironment.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
牙周炎通过 PD-1/PD-L1 促进肿瘤生长和免疫逃避。
研究背景我们的研究探讨了实验性牙周炎对口腔鳞状细胞癌(OSCC)和前列腺癌的肿瘤生长、局部和全身免疫抑制状态以及程序性死亡受体1(PD-1)/程序性死亡配体1(PD-L1)表达的影响:小鼠口腔癌或前列腺癌异种移植模型分为对照组、牙周炎组和牙周炎+抗PD-1组。记录肿瘤体积和重量,用流式细胞术或免疫荧光法检测相关免疫抑制细胞和 T 细胞的水平。使用 LPS 刺激 Cal-27 细胞的条件培养基刺激 THP-1 细胞,并通过实时定量 PCR、Western 印迹和免疫荧光检测 PD-L1 的表达。研究人员还收集了有牙周炎或无牙周炎的 OSCC 患者的肿瘤标本进行免疫荧光:结果:牙周炎明显增加了肿瘤的体积和重量。与对照组相比,牙周炎组肿瘤相关巨噬细胞(TAMs)、调节性T细胞(Tregs)、PD-L1+TAMs和PD-1+CD8+T细胞的比例增加,而CD8+T细胞的比例减少。免疫荧光显示,在牙周炎的异种移植物和临床 OSCC 样本中,PD-L1+TAMs 和 PD-1+CD8+T 细胞增加,但 IFN-γ+CD8+T 细胞减少。在体外,与未受刺激的 Cal-27 细胞相比,LPS 刺激的 Cal-27 细胞具有更强的诱导巨噬细胞表达 PD-L1 的潜力。结论:牙周炎可能会促进肿瘤的生长和免疫逃避:结论:牙周炎可通过增强肿瘤微环境中 PD-1/PD-L1 的表达,促进肿瘤的生长和免疫逃逸,表现为免疫抑制细胞的增加和功能性 T 细胞的减少。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
10.50
自引率
1.70%
发文量
207
审稿时长
1 months
期刊介绍: Cancer Immunology, Immunotherapy has the basic aim of keeping readers informed of the latest research results in the fields of oncology and immunology. As knowledge expands, the scope of the journal has broadened to include more of the progress being made in the areas of biology concerned with biological response modifiers. This helps keep readers up to date on the latest advances in our understanding of tumor-host interactions. The journal publishes short editorials including "position papers," general reviews, original articles, and short communications, providing a forum for the most current experimental and clinical advances in tumor immunology.
期刊最新文献
HLA-G high-expressor 3'UTR markers are linked to gastric cancer development and survival. Hepatitis associated with immune checkpoint inhibitors-based combinations of other therapies: A real-world pharmacovigilance analysis based on the FDA adverse event reporting system (FAERS) database. Hepatic arterial infusion chemotherapy combined with systemic therapy sequentially or simultaneously for advanced hepatocellular carcinoma. "Tumor immunology meets oncology" (TIMO), 18 April-20 April 2024, in Brandenburg an der Havel, Germany. Cryo-thermal therapy reshaped the tumor immune microenvironment to enhance the efficacy of adoptive T cell therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1